Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mireille Langouo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|January 27, 2025
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?Michel Meyers, Oumnia Mouna, Mireille Langouo
Current Opinion in Oncology|February 18, 2026
Melanoma in adolescents and young adults: special considerationsSofie Abboud, Luigi Romano, Mireille Langouo Fontsa
Seminars in Cancer Biology|March 26, 2018
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancerGrégory Noël, Mireille Langouo Fontsa, Karen Willard-Gallo
Current Opinion in Oncology|January 27, 2025
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapyOumnia Mouna, Charlotte Hanssens, Michel Meyers, et al.
Expert Review of Clinical Immunology|July 15, 2024
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapyMireille Langouo Fontsa, Francine Padonou, Karen Willard-Gallo
Current Opinion in Oncology|August 9, 2022
Biomarkers and immunotherapy: where are we?Mireille Langouo Fontsa, Francine Padonou, Karen Willard-Gallo
Case Reports in Oncology|October 30, 2023
Trocar Site Recurrence after Laparoscopic Cholecystectomy for Unsuspected Isolated Gallbladder Metastasis of Melanoma: A Case Report and Review of the LiteratureCéline Sergeant, Joseph Kerger, Annie Drowart, et al.
International Journal of Oncology|November 22, 2024
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profilesPhilippe G Aftimos, Murielle Wiedig, Mireille Langouo Fontsa, et al.
International Journal of Oncology|July 10, 2013
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profilesPhilippe G Aftimos, Murielle Wiedig, Mireille Langouo Fontsa, et al.
Targeted Oncology|September 14, 2022
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New ResearchMireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|January 27, 2025
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?Michel Meyers, Oumnia Mouna, Mireille Langouo
Current Opinion in Oncology|February 18, 2026
Melanoma in adolescents and young adults: special considerationsSofie Abboud, Luigi Romano, Mireille Langouo Fontsa
Seminars in Cancer Biology|March 26, 2018
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancerGrégory Noël, Mireille Langouo Fontsa, Karen Willard-Gallo
Current Opinion in Oncology|January 27, 2025
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapyOumnia Mouna, Charlotte Hanssens, Michel Meyers, et al.
Expert Review of Clinical Immunology|July 15, 2024
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapyMireille Langouo Fontsa, Francine Padonou, Karen Willard-Gallo
Current Opinion in Oncology|August 9, 2022
Biomarkers and immunotherapy: where are we?Mireille Langouo Fontsa, Francine Padonou, Karen Willard-Gallo
Case Reports in Oncology|October 30, 2023
Trocar Site Recurrence after Laparoscopic Cholecystectomy for Unsuspected Isolated Gallbladder Metastasis of Melanoma: A Case Report and Review of the LiteratureCéline Sergeant, Joseph Kerger, Annie Drowart, et al.
International Journal of Oncology|November 22, 2024
[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profilesPhilippe G Aftimos, Murielle Wiedig, Mireille Langouo Fontsa, et al.
International Journal of Oncology|July 10, 2013
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profilesPhilippe G Aftimos, Murielle Wiedig, Mireille Langouo Fontsa, et al.
Targeted Oncology|September 14, 2022
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New ResearchMireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, et al.
Pageof 2